N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification.
about
Measurement of nonsulfated cholecystokinins.Normalization of elevated cardiac, kidney, and hemolysis plasma markers within 48 h in Mexican Tarahumara runners following a 78 km race at moderate altitude.MR-proANP improves prediction of mortality and cardiovascular events in patients with STEMI.Cardiac Dysfunction in a Porcine Model of Pediatric Malnutrition.Plasma pro-atrial natriuretic peptide to estimate fluid balance during open and robot-assisted esophagectomy: a prospective observational studyPlasma pro-atrial natriuretic peptide to indicate fluid balance during cystectomy: a prospective observational study.ProANP plasma measurement predicts all-cause mortality in acutely hospitalised patients: a cohort study.Three molecular forms of atrial natriuretic peptides: quantitative analysis and biological characterization.Hemoglobin mass and intravascular volume kinetics during and after exposure to 3,454-m altitude.Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males.Transient cardiac dysfunction but elevated cardiac and kidney biomarkers 24 h following an ultra-distance running event in Mexican Tarahumara.Erythropoiesis with endurance training: dynamics and mechanisms.Plasma volume reduction and hematological fluctuations in high-level athletes after an increased training load.Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.Reduction in central venous pressure enhances erythropoietin synthesis: role of volume-regulating hormones.
P2860
Q34415302-9883DDF3-B491-430D-AB01-48AEC329C1A8Q34541089-5319FFB8-A555-4526-BD13-DA21F3DCE0B9Q34662255-98383278-412E-48C1-953F-36C78901A2D1Q35810369-22ECDB36-7DE1-4D7F-A325-1671C6852D8CQ36270396-BC414159-4D14-4E51-8CA2-66FE3B1D28C4Q36625220-12516AC7-642E-4F14-A49C-46490FFAF8C8Q37352819-A401F3C7-A31F-4394-BFC5-891795FDFE59Q39102349-4FF554B4-613E-451B-946B-C1BE618436D4Q41272626-406CAEF7-29CF-464D-86E7-69C1D70EE90CQ41886690-CF79B91E-FD81-43A5-BABD-21E7C9C389B5Q47111655-D022B37D-4839-478D-BA13-3CFF803F7C02Q50211526-1DDD0F61-FBDD-4EA0-BFE5-6B7DB77C4DAAQ50922798-F37B10FC-0939-4D2B-A7E9-D86DDDB5291CQ51000313-D228D662-CF7F-4629-A86E-7D77F7965B1EQ53609730-C0EDAF76-2A00-48E7-A270-D21658BD9C90
P2860
N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
N-terminal pro-atrial natriure ...... uggests covalent modification.
@en
N-terminal pro-atrial natriure ...... uggests covalent modification.
@nl
type
label
N-terminal pro-atrial natriure ...... uggests covalent modification.
@en
N-terminal pro-atrial natriure ...... uggests covalent modification.
@nl
prefLabel
N-terminal pro-atrial natriure ...... uggests covalent modification.
@en
N-terminal pro-atrial natriure ...... uggests covalent modification.
@nl
P2093
P1433
P1476
N-terminal pro-atrial natriure ...... uggests covalent modification.
@en
P2093
Dan L Crimmins
Ingrid Hunter
Jens F Rehfeld
Jens P Goetze
Ulf Dahlström
Urban Alehagen
P304
P356
10.1373/CLINCHEM.2011.166330
P407
P577
2011-06-29T00:00:00Z